Analytical Validation of an Ultra-sensitive Personalized Circulating Tumor DNA Assay: NeXT Personal®
March 20, 2024
PRESS RELEASE: On March 14, 2024, a new research paper was published in Oncotarget, entitled, “Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay.” continue reading »